Kynurenine 3-monooxygenase (KMO) polymorphisms in schizophrenia: An association study

Schizophrenia Research

Volumn 127, Issue 1-3, 2011, Pages 270-272

  Holtze, Maria ^a   Saetre, Peter ^a   Erhardt, Sophie ^b   Schwieler, Lilly ^c   Werge, Thomas ^d   Hansen, Thomas ^d   Nielsen, Jimmi ^e   Djurovic, Srdjan ^a,f   Melle, Ingrid ^a   Andreassen, Ole A ^a   Hall, Håkan ^b   Terenius, Lars ^a   Agartz, Ingrid ^a,b   Engberg, Göran ^b   Jönsson, Erik G ^a   Schalling, Martin ^d  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Mental Health Services CPH   (Denmark)

^c AALBORG UNIVERSITY HOSPITAL   (Denmark)

^d ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^e UNIVERSITY OF OSLO   (Norway)

^f DIAKONHJEMMET HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

KYNURENINE 3 MONOOXYGENASE;

CASE CONTROL STUDY; CONTROLLED STUDY; DENMARK; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; LETTER; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; NORWAY; PRIORITY JOURNAL; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SCHIZOPHRENIFORM DISORDER; SINGLE NUCLEOTIDE POLYMORPHISM; SWEDEN;

EID: 79952316835     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2010.10.002     Document Type: Letter

References (8)

1. Aoyama N., Takahashi N., Saito S., Maeno N., Ishihara R., Ji X., Miura H., Ikeda M., Suzuki T., Kitajima T., Yamanouchi Y., Kinoshita Y., Yoshida K., Iwata N., Inada T., Ozaki N. Association study between kynurenine 3-monooxygenase gene and schizophrenia in the Japanese population. Genes Brain. Behav. 2006, 5(4):364-368.
2. Ekelund J., Hennah W., Hiekkalinna T., Parker A., Meyer J., Lonnqvist J., Peltonen L. Replication of 1q42 linkage in Finnish schizophrenia pedigrees. Mol. Psychiatry 2004, 9(11):1037-1041.
3. Erhardt S., Olsson S.K., Engberg G. Pharmacological manipulation of kynurenic acid: potential in the treatment of psychiatric disorders. CNS Drugs 2009, 23(2):91-101.
4. Hamshere M.L., Bennett P., Williams N., Segurado R., Cardno A., Norton N., Lambert D., Williams H., Kirov G., Corvin A., Holmans P., Jones L., Jones I., Gill M., O'Donovan M.C., Owen M.J., Craddock N. Genomewide linkage scan in schizoaffective disorder: significant evidence for linkage at 1q42 close to DISC1, and suggestive evidence at 22q11 and 19p13. Arch. Gen. Psychiatry 2005, 62(10):1081-1088.
5. Jönsson E.G., Saetre P., Vares M., Andreou D., Larsson K., Timm S., Rasmussen H.B., Djurovic S., Melle I., Andreassen O.A., Agartz I., Werge T., Hall H., Terenius L. DTNBP1, NRG1, DAOA, DAO and GRM3 polymorphisms and schizophrenia: an association study. Neuropsychobiology 2009, 59:142-150.
6. Linderholm, K.R., Skogh, E., Olsson, S.K., Dahl, M.L., Holtze, M., Engberg, G., Samuelsson, M., Erhardt, S., 2010. Increased levels of kynurenine and kynurenic acid in the CSF of patients with schizophrenia. Schizophr. Bull. DOI:10.1093/schbul/sbq086.
7. Moroni F. Tryptophan metabolism and brain function: focus on kynurenine and other indole metabolites. Eur. J. Pharmacol. 1999, 375(1-3):87-100.
8. Wonodi I., Schwarcz R. Cortical kynurenine pathway metabolism: a novel target for cognitive enhancement in Schizophrenia. Schizophr. Bull. 2010, 36(2):211-218.